Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03489837Phase 3Completed
A Phase 3 trial of levodropropizine in acute bronchitis, chronic bronchitis (CB), sponsored by Hyundai Pharmaceutical Co., Ltd.. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03489837.